NEXMOS

Nexmos is a South Korean biotechnology company specializing in the development of DNA aptamer-based technologies to stabilize and enhance the delivery of sensitive molecules. The company's core platform, Aptamin, focuses on creating DNA aptamers that bind to and protect antioxidants like Vitamin C from oxidation, significantly increasing their efficacy in topical and systemic applications. Nexmos is leveraging this technology to develop a pipeline of therapeutics for neurodegenerative disorders, including Parkinson's and Alzheimer's diseases, by targeting oxidative stress and protein aggregation. In addition to its pharmaceutical pursuits, the company commercializes aptamer-enhanced ingredients for the dermo-cosmetic and nutraceutical markets.